» Articles » PMID: 22955228

Independent of Nephrectomy, Weaning Immunosuppression Leads to Late Sensitization After Kidney Transplant Failure

Overview
Journal Transplantation
Specialty General Surgery
Date 2012 Sep 8
PMID 22955228
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients returning to dialysis therapy after renal transplant failure have a high rate of human leukocyte antigen antibody sensitization, and sensitization has been linked to allograft nephrectomy. We hypothesized that nephrectomy for cause is a consequence of weaning immunosuppression and that weaning leads to sensitization even in the absence of nephrectomy.

Methods: We examined outcomes in 300 consecutive patients with kidney allograft failure and survival of more than 30 days after failure. We analyzed a subset of 119 patients with a low panel reactive antibody (PRA) before transplantation and follow-up PRA testing at 6 to 24 months after failure (late PRA).

Results: By late PRA testing, 56% of patients were highly sensitized (class I or II PRA ≥80%). On multivariate analysis controlling for human leukocyte antigen matching, allograft nephrectomy, and other variables, weaning of immunosuppression predicted high sensitization (odds ratio, 14.34; P=0.004). In a subset of patients, the percentage of those who were highly sensitized increased from 21% at the time of failure on immunosuppressive therapy to 68% by late PRA after weaning (P<0.001). Conversely, patients who maintained immunosuppression showed minimal sensitization after failure. Transplant nephrectomy was required in 41% of patients who weaned immunosuppression versus 0% of the 24 patients who maintained immunosuppression with calcineurin inhibitor therapy after failure (P<0.001).

Conclusions: Weaning immunosuppression was a triggering event leading to late rejection and allograft nephrectomy and was an independent predictor of alloantibody sensitization after kidney allograft failure.

Citing Articles

Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure.

Tran J, Alrajhi I, Chang D, Sherwood K, Keown P, Gill J Front Genet. 2024; 15:1383220.

PMID: 38638120 PMC: 11024336. DOI: 10.3389/fgene.2024.1383220.


Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score Analysis.

Noelle J, Mayet V, Lambert C, Couzi L, Chauveau B, Thierry A Transpl Int. 2023; 36:11775.

PMID: 37799669 PMC: 10548547. DOI: 10.3389/ti.2023.11775.


Continuation of immunosuppression vs. immunosuppression weaning in potential repeat kidney transplant candidates: a care management perspective.

Hickey M, Singh G, Lum E Front Nephrol. 2023; 3:1163581.

PMID: 37746029 PMC: 10513023. DOI: 10.3389/fneph.2023.1163581.


Dialysis after kidney transplant failure: how to deal with this daunting task?.

Tanriover C, Copur S, Basile C, Ucku D, Kanbay M J Nephrol. 2023; 36(7):1777-1787.

PMID: 37676635 DOI: 10.1007/s40620-023-01758-x.


Allograft nephrectomy vs. no nephrectomy for failed renal transplants.

McDonald M Front Nephrol. 2023; 3:1169181.

PMID: 37675360 PMC: 10479781. DOI: 10.3389/fneph.2023.1169181.